H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.1% of adults in Fargo have diagnosed diabetes — 3.9 points below the U.S. 12% figure. Census population 125,990. North Dakota Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Fargo clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Fargo storefront.
Extracellular Matrix (ECM) Therapy in Fargo, ND for clinics & physicians. ECM therapy products provide nat… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 8.1% of adults in Fargo have diagnosed diabetes — 3.9 points below the U.S. 12% figure. Census city-proper population is 125,990. If you are adding extracellular matrix therapy, start with that epidemiology and with Noridian Healthcare Solutions (JF) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Extracellular Matrix (ECM) Therapy notes (how the product actually works)CDC PLACES (2023, crude) estimates 8.1% of adults in Fargo have diagnosed diabetes — 3.9 points below the U.S. 12% figure. Adult obesity in Fargo is 34.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JF / Noridian Healthcare Solutions, sibling states AK, AZ, ID, MT, OR, SD, UT, WA, WY. North Dakota Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Fargo warehouse or a five-star local review. What you get is extracellular matrix therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JF, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 8.1% of adults — 3.9 points below the U.S. 12% figure. Obesity is 34.3%; arthritis is 21.2%. That is place-level BRFSS modeling, not a clinic census and not a Fargo trial.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JF reviewers and surveyors expect — not a brochure.
Body copy and schema dateModified follow a pinned content version date, not a daily timestamp. CDC and CMS figures are cited to the public reports named on the page. Recheck MAC LCDs before each utilization change — those move faster than a landing page.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Ask for the IFU, the lot-traceability packet, and the Noridian Healthcare Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Fargo fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Fargo, ND.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Fargo is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Fargo — 3.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Dakota Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, OR, SD, UT, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Fargo. Useful for joint-program math; still needs a diagnosis and privileging.
No Fargo storefront. Joe Bradley is an active practice owner. extracellular matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.